Amgen Inc. (AMGN) is a biotechnology firm that discovers, develops, manufactures, and markets human therapeutics based on advances in cellular and molecular biology for grievous illnesses. Q2 2012 Highlights The company reported striking figures for Q2 2012. Amgen’s total revenues increased 13 percent to $4,477 million, with 8 percent product sales growth driven by strong […]

AT&T (NYSE:T) is the largest provider of mobile telephony. In 2011, Forbes listed AT&T as the 14th largest company in the world by market value and the 9th largest non-oil company in the world by market value. AT&T Inc. provides telecommunications services and next-generation TV innovations to consumers, businesses, and other providers nationwide with the […]

We recommend a buy for Nike (NKE) as it exhibits a strong revenue growth, steady fundamentals, successful share buybacks, and a consistent lead in the industry mostly in terms of valuation. The freshly released fiscal Q1 report reiterated and surpassed analysts’ expectations on revenue and EPS. PROFITABILITY Nike posted EPS of $1.23 compared to analysts expected $1.12, […]